Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Richard D Francis

CEO, President at Teva Pharmaceutical Industries Ltd (TEVA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $31.3M

Reported trades

Filed Stock Type Shares Price Value Since
Jun 8SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 6,1531,177,529 held (−1%) $34.35 $211K +19.7%
Mar 9SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 20,0251,170,639 held (−2%) $31.67 $634K +29.8%
Mar 6SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 23,3931,148,212 held (−2%) $32.46 $759K +26.6%
Mar 5SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 30,903642,099 held (−5%) $32.36 $1.0M +27.0%
Mar 5SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 412,0321,121,382 held (−27%) $32.36 $13.3M +27.0%
Feb 18SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 161,656271,783 held (−37%) $34.22 $5.5M +20.1%
Feb 18SEC TEVATeva Pharmaceutical Industries Ltd Sell Plan 286,122605,771 held (−32%) $34.22 $9.8M +20.1%
  • Sell

    CEO, President Richard D Francis sold $211K of TEVA at $34.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Richard D Francis sold $634K of TEVA at $31.67 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Richard D Francis sold $759K of TEVA at $32.46 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Richard D Francis sold $1.0M of TEVA at $32.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Richard D Francis sold $13.3M of TEVA at $32.36 — cuts the stake by 27%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, President Richard D Francis sold $5.5M of TEVA at $34.22 — cuts the stake by 37%; pre-scheduled 10b5-1 plan sale.